Insulet, a provider of tubeless insulin pump technology via its Omnipod brand of products, launched the syndication of new senior secured credit facilities consisting of a senior secured revolving facility and a senior secured term loan B facility.
The closing of the senior secured credit facilities and the terms thereof are subject to obtaining lender commitments as well as market and other conditions. Insulet intends to use the proceeds of the senior secured credit facilities for general corporate purposes, including to retire indebtedness and/or to fund investments.
Morgan Stanley is acting as lead arranger and active bookrunner for the transaction.
